Skip to main content
Year archive

Eutilex Co.,Ltd. — 2021 filings

All 47 regulatory filings released by Eutilex Co.,Ltd. (263050) in 2021, sourced directly from the official regulator.

47 Filings
2021 Period
2021 filings (47)
Filing Released Lang
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-12-30 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-15 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-11-04 Korean
전환가액의조정(제1회차 CB)
Capital/Financing Update
2021-11-04 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-11-02 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-10-22 Korean
[기재정정]반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-10-22 Korean
투자판단관련주요경영사항(앱비앤티셀의 임상1/2a상 적응증 추가 임상시험계획 승인)
Regulatory Filings
2021-10-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-09-15 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-09-01 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2021-08-04 Korean
전환가액의조정
Share Issue/Capital Change
2021-08-04 Korean
투자판단관련주요경영사항(앱비앤티셀의 임상1/2a상 적응증 추가 임상시험계획 신청)
Regulatory Filings
2021-07-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-07-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-06-25 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update
2021-06-03 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2021-05-20 Korean
전환가액의조정
Share Issue/Capital Change
2021-05-20 Korean
전환가액의조정
Share Issue/Capital Change
2021-05-20 Korean
투자판단관련주요경영사항(면역항암제 EU101의 임상 1/2상 시험 계획 승인 )
Regulatory Filings
2021-05-17 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-17 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update
2021-05-13 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2021-05-12 Korean
기타경영사항(특허권취득)(자율공시)
Regulatory Filings
2021-04-20 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-04-16 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2021-03-31 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-23 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-23 Korean
[기재정정]주주총회소집공고
AGM Information
2021-03-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-17 Korean
주주총회소집결의
AGM Information
2021-03-16 Korean
주주총회집중일개최사유신고
AGM Information
2021-03-16 Korean
주주총회소집공고
AGM Information
2021-03-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-03-04 Korean
투자판단관련주요경영사항(면역항암제 EU101의 임상 1/2상 시험 계획 신청)
Regulatory Filings
2021-02-18 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-02-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-02-05 Korean
기업설명회(IR)개최
Report Publication Announcement
2021-01-21 Korean
기타경영사항(특허권취득)(자율공시)(항 인간 VSIG4 항체와 그 용도 (Anti-human VSIG4 antibodies and uses thereof))
Regulatory Filings
2021-01-19 Korean